DIALYSIS · CCN 492626

DaVita Fair Oaks Dialysis

FAIRFAX, VA 22030

DialysisProfitDaVita
$3.1M
TOTAL REVENUE
32.9%
OPERATING MARGIN
4 / 5
STAR RATING
12
QUALITY MEASURES
DaVita
CHAIN
01 — FINANCIAL

Cost report financials (FY2025)

Net patient revenue
$3.1M
Total costs
$2.1M
Operating income (rev − costs)
$1.0M
Operating margin
32.9%
Total charges
$3.3M
Total treatments
7,399
Dialysis stations
13

Source: CMS dialysis cost reports. Operating margin = (net patient revenue − total costs) / net patient revenue.

02 — QUALITY MEASURES

12 quality measures

MeasureScoreDenominatorPeriod
Standardized ED Visits Within 30 Days of Hospital Discharge
DFC_ED30
0.8734—
Fistula Rate
DFC_FISTULA_RATE
84.158—
Five Star Rating
DFC_FIVE_STAR
4——
Healthcare Worker COVID-19 Vaccination Adherence
DFC_HCP_VACC
3——
Patient Hospitalization Rate
DFC_HOSPITALIZATION_RATE
112.245—
Standard Infection Ratio (SIR)
DFC_INFECTION_RATIO
0.3——
Percentage of Adult Patients with Long Term Catheter in Use
DFC_LONG_CATHETER
1158—
Patient Survival (Mortality Rate)
DFC_MORTALITY_RATE
27.7181—
Percentage of Prevalent Patients Waitlisted for Kidney Transplant
DFC_PPPW
23.737—
Patient Hospital Readmission Rate
DFC_READMISSION_RATE
22.727—
Standardized ED Visits Ratio
DFC_SEDR
1.8528—
Patient Transfusion Rate
DFC_TRANSFUSION_RATE
53.425—